Definitive Contract W911QY18C0010
Award Date 11/13/17
Potential Completion Date 10/31/19
Potential Value $240K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21202, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Army Combat Capabilities Development Command (CCDC) awarded a $249,970 firm-fixed-price definitive contract to Intralytix Inc. on February 13, 2025, to develop and optimize a stable dry formulation of PhageSafe, a bacteriophage-based antimicrobial preparation targeting three major foodborne bacterial pathogens of concern to the Army: Listeria monocytogenes, Salmonella, and Escherichia coli STEC. The contract, which originated from a Broad Agency Announcement seeking basic and applied...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Specific Diagnostics, Inc., a for-profit small business, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development titled "Rapid Bacteriophage Susceptibility Testing Using Small Molecule Sensor Technology" and has a potential value of $248,845.27. The contract was awarded on March 2, 2021, with an expected completion date of...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price Definitive Contract to Adaptive Phage Therapeutics, Inc. to develop a rapid and scalable method for bacteriophage manufacture and purification under the Small Business Innovation Research (SBIR) Phase I program. The contract has a potential value of $296,787.00 and a completion date of August 15, 2022. This contract is not set...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
- The U.S. Army Medical Command awarded a $250,000.00 firm fixed price purchase order to the Eliava Foundation-Association For Development Of Bacteriophages In Georgia, a non-profit organization, to conduct a clinical observation study to advance the knowledge on the application of bacteriophage treatments for wound infections. The study will be performed on-site in Georgia and includes medical treatment in accordance with an approved protocol. This award is not associated with a larger contract...
- This federal contract award was issued by the Defense Health Agency (DHA) to Charlot Biosciences Inc., a minority-owned, small disadvantaged business, for a Phase I Small Business Innovation Research (SBIR) project titled "Rapid Detection of Bacteriophage Susceptibility in Antibiotic-Resistant Pathogens Using Cellphoresis". The firm-fixed-price purchase order has a potential value of $249,534.00 and a completion date of September 7, 2021. The contract is set aside for small...
- This $297,740 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CFD Research Corporation, a small business in Huntsville, Alabama. The contract is for the "Development of Bacteriophage for Treatment of Mycobacterial Infections", under SBIR Topic 131 from the SBIR/STTR solicitation PHS-2023-1. CFD Research specializes in engineering...
- The Department of the Army Materiel Command Research Development and Engineering Command awarded a firm fixed price contract valued at ninety-nine thousand nine hundred sixty-eight dollars to The Charles Stark Draper Laboratory, Inc. (Draper) to identify bacteriophages under Task 1 of an unspecified effort. No set-aside designation applied. Performance will occur in Natick, Massachusetts with an anticipated completion date of October 31, 2021. As a not-for-profit research organization, Draper...
- The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a "Portable Automated Phage Isolation Technology." This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...
- This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...